Description

BSE announces listing of further securities issued by 7 companies under Employee Stock Option Plans, effective November 11, 2025.

Summary

BSE has announced the listing and admission to trading of further securities issued by 7 companies under their Employee Stock Option Plans (ESOP) and Employee Stock Option Schemes (ESOS). These securities will be available for trading effective Tuesday, November 11, 2025. The circular covers a total of 902,324 shares across the seven companies, with varying lock-in periods.

Key Points

  • 7 companies have issued further securities under ESOP/ESOS schemes
  • Total of 902,324 new shares to be listed
  • Trading commences from November 11, 2025
  • Companies include Arvind Fashions, Bliss GVS Pharma, Carborundum Universal, Edelweiss Financial Services, IIFL Capital Services, Mphasis, and UNO Minda
  • Lock-in periods vary by company - some securities have no lock-in while others are locked until April 10, 2026
  • Face values range from Re 1 to Rs 10 depending on the company

Company-wise Details

1. Arvind Fashions Limited

  • Scrip Code: 542484
  • ISIN: INE955V01021
  • Shares: 22,279
  • Face Value: Rs 4
  • Lock-in: None

2. Bliss GVS Pharma Limited

  • Scrip Code: 506197
  • ISIN: INE416D01022
  • Shares: 39,450
  • Face Value: Re 1
  • Lock-in: Until April 10, 2026

3. Carborundum Universal Ltd.

  • Scrip Code: 513375
  • ISIN: INE120A01034
  • Shares: 3,000
  • Face Value: Re 1
  • Lock-in: None

4. Edelweiss Financial Services Ltd.

  • Scrip Code: 532922
  • ISIN: INE532F01054
  • Shares: 367,683
  • Face Value: Re 1
  • Lock-in: None

5. IIFL Capital Services Limited

  • Scrip Code: 542773
  • ISIN: INE489L01022
  • Shares: 252,550
  • Face Value: Rs 2
  • Lock-in: None

6. Mphasis Limited

  • Scrip Code: 526299
  • ISIN: INE356A01018
  • Shares: 155,762
  • Face Value: Rs 10
  • Lock-in: None

7. UNO Minda Limited

  • Scrip Code: 532539
  • ISIN: INE405E01023
  • Shares: 61,600
  • Face Value: Rs 2
  • Lock-in: None

Regulatory Changes

No regulatory changes are introduced through this circular. This is a standard listing notification for securities issued under existing ESOP/ESOS frameworks.

Compliance Requirements

  • Trading members are informed to take note of the new securities available for trading
  • Companies must ensure compliance with lock-in requirements where applicable
  • Securities under lock-in (Bliss GVS Pharma) cannot be traded until the specified lock-in expiry date

Important Dates

  • Notice Date: November 10, 2025
  • Listing Effective Date: November 11, 2025 (Tuesday)
  • Lock-in Expiry (Bliss GVS Pharma only): April 10, 2026

Impact Assessment

Market Impact: Low. The listing of ESOP/ESOS shares is a routine corporate action with minimal market impact. The quantities being listed represent a small fraction of the total outstanding shares of these companies.

Liquidity Impact: Marginal increase in float for the respective companies, with most shares having no lock-in restrictions and immediately available for trading.

Shareholder Impact: Dilution effect is minimal given the relatively small number of shares compared to existing equity base. Employees receiving these shares can monetize their holdings (subject to lock-in periods).

Operational Impact: No operational changes required for trading members beyond noting the availability of additional shares for trading.

Impact Justification

Routine listing of ESOP/ESOS shares for existing listed companies with minimal market impact